The Blog
Science. Strategy. Results.
Stopping Ozempic or Zepbound? What the Data Says About Weight Regain (and How to Keep It Off)
Most people regain a meaningful share of lost weight within a year of stopping a GLP-1. Here's what the data shows — and the five evidence-backed levers for keeping it off.
Orforglipron vs. the Wegovy Pill: The 2026 Oral GLP-1 Showdown
Two oral GLP-1s. One is a peptide with strict food rules; the other is a small molecule you can swallow with breakfast. Here's how Wegovy oral and orforglipron actually compare.
GLP-1 Microdosing: What It Is, Why It's Trending, and What Doctors Say
Microdosing semaglutide and tirzepatide exploded in 2026. Here's what the trend actually is, what the evidence shows, and why endocrinologists are pushing back on the DIY playbook.
The GLP-1 Revolution Just Got a Pill: 7 Shifts Reshaping Weight Loss, Peptide Therapy, and Metabolic Health in 2026
The GLP-1 landscape just changed dramatically. From the new oral Wegovy pill to peptide stacking and emerging brain benefits — here's what every patient needs to know in 2026.
Peptides for Health in 2026: Benefits, Types, and New US Laws Making Them Easier to Access Than Ever
BPC-157, CJC-1295, Thymosin Alpha-1 — the new frontier of recovery, anti-aging and metabolic health, and how 2026 legislation makes access easier.
Ozempic vs. Wegovy: Understanding the Differences and Their Impact on Health and Diet
Same drug, different doses, different goals. Here's what every patient should know before choosing between Ozempic and Wegovy.
Maintaining a Healthy Weight with Ozempic: Your Diet Matters
Before, during, and after Ozempic — a practical nutrition framework for protecting muscle, energy, and long-term metabolic health.